AUA 2018

AUA 2018: Pretreatment Diagnosis of the Small Renal Mass: Status of Renal Biopsy in the US

San Francisco, CA ( Renal tumor biopsy is now recognized as a safe procedure with limited risks compared to historical series. The theoretical risk of seeding has not been seen in more recent series. Improved biopsy technique has improved yield. However, uptake has been limited by the general medical community and is often reserved for patients who active surveillance is considered, especially in patients who are not good surgical candidates.

AUA 2018: Evaluation of Bacterial Biofilms on Renal Calculi

San Francisco, CA USA ( Negar Motayagheni, MD, from the Wake Forest School of Medicine, presented data regarding the relevance of bacterial biofilms on and in renal calculi and urine culture to establish a cause for sepsis. He prefaced his research by stating bacterial biofilms have been found anchored on indwelling medical devices and in UTIs. Motayagheni hypothesized that the presence and aggregation of bacteria on uroliths can be a cause for sepsis.

AUA 2018: Variability in Partial Nephrectomy Outcomes: Does Your Surgeon Matter?

San Francisco, CA USA ( Recently, there have been many publications citing the difference amongst surgeon skill and technique in partial nephrectomy. Julien Dagenais, MD emphasized these articles in the beginning of his talk by mentioning fifteen articles surrounding this topic. Understanding discrepancies between surgeons is increasingly important in the pursuit of quality-based healthcare in the United States.

AUA 2018: Diagnostic Value of 68GA-Labelled PSMA PET/CT Imaging for Renal Cell Carcinoma

San Francisco, CA ( PSMA (prostate specific membrane antigen) is a targetable receptor that has high specificity for prostate cancer, and as such, PSMA PET scans have been gaining significant traction in the management of recurrent prostate cancer to identify low-volume recurrent disease. Yet, despite its high specificity for prostate cancer, it is known to be expressed in other benign tissues – and occasionally other malignancies.

AUA 2018: A Catheter Insertion Force Assessment Tool: Design and Preclinical Results

San Francisco, CA USA ( Xiaoyin Ling, master mechanical engineering student from the University of Minnesota, presented data that evaluated the efficacy of a novel catheter insertion force assessment tool for quantitatively measuring the force of urinary catheter insertion in situ. As an introduction, Ms. Ling explained how despite urethral catheterization being among the most common procedures performed, there is no standardized approach to Foley catheter insertion.

AUA 2018: Improved Efficiency of Holmium Laser Lithotripsy with Suction Stabilization and Containment of Fragments

San Francisco, CA USA ( Ali H. Aldoukhi, MD, clinical urology fellow from the University of Michigan, Ann Arbor, presented data that evaluated the efficacy of laser lithotripsy of a prototype device that utilizes suction stabilization and stone confinement during in-vitro laser lithotripsy. As an introduction, Dr. Aldoukhi explained because stones and stone fragments retropulse away from the laser’s target zone, a lot of time and energy during ureteroscopy is spent re-localizing, targeting, and extracting residual stone fragments.

AUA 2018: Prostate Biopsy Centralization at High Volume, Tertiary Care Centers Represents the Most Refined Diagnostic Tool for Prostate Cancer Patients

San Francisco, CA ( In an increasingly individualized prostate cancer (PCa) care, discordance between prostate biopsy and radical prostatectomy (RP) should be minimal. In tertiary care centers prostate biopsies may be performed more accurately due to adherence to strict protocols. In this study the authors aimed to evaluate the impact of centralized biopsy on PCa diagnostic accuracy.